Clinical Trial: A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase II Study to Evaluate the Efficacy, Tolerability, and Safety of VBP-245 in Pediatric Subjects for the Treatment of Number of lesions from baseline to day 60 will be counted and the reduction in number will be recorded.



Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Veloce BioPharma LLC

Dates:
Date Received: January 31, 2017
Date Started: February 27, 2017
Date Completion: December 2017
Last Updated: March 7, 2017
Last Verified: March 2017